Introduction: This blog offers a focused MCQ collection on ACTD (ASEAN Common Technical Dossier) usage in Asian regulatory submissions, tailored for M.Pharm students studying Regulatory Aspects of Drugs & Cosmetics. The questions explore dossier structure, Module 1 country-specific requirements, harmonized Modules 2–5, stability considerations for tropical climates, eCTD versus ACTD, bridging and bioequivalence needs, and common pitfalls during submission. Each MCQ reinforces practical knowledge required for preparing regulatory submissions in Asian markets, highlighting differences between regional and ICH expectations. Use these questions to test and deepen your understanding of dossier compilation, country adaptations, and strategies for successful product registration across Asia.
Q1. What does ACTD stand for in the context of Asian regulatory submissions?
- ASEAN Common Technical Dossier
- Asian Clinical Trial Dossier
- Application for Country-specific Technical Data
- Advanced Chemical Therapeutic Dossier
Correct Answer: ASEAN Common Technical Dossier
Q2. Which module of the ACTD contains country-specific administrative information such as application forms, labeling and local regulatory certificates?
- Module 1
- Module 2
- Module 3
- Module 5
Correct Answer: Module 1
Q3. Which set of ACTD modules are generally harmonized across regions and contain the scientific data for quality, nonclinical and clinical aspects?
- Modules 2–5
- Modules 1–2
- Module 3 only
- Module 1 and Module 5
Correct Answer: Modules 2–5
Q4. In the ACTD, which module specifically contains Chemistry, Manufacturing and Controls (CMC) documentation?
- Module 3
- Module 2
- Module 4
- Module 1
Correct Answer: Module 3
Q5. Which module of the ACTD contains the clinical overviews and summaries synthesizing the full clinical data?
- Module 2
- Module 3
- Module 4
- Module 1
Correct Answer: Module 2
Q6. Which of the following is typically included in Module 1 of ACTD submissions?
- Local labeling, patient information leaflet and application forms
- Full batch manufacturing records
- Complete clinical study reports
- Nonclinical toxicology raw data
Correct Answer: Local labeling, patient information leaflet and application forms
Q7. What best describes the eCTD standard used for electronic submissions compared with ACTD?
- An XML backbone with PDF documents enabling lifecycle management of submissions
- A paper-only dossier intended for postage to regulatory agencies
- A non-structured PDF file with no sequence management
- A proprietary word-processing format used in ASEAN only
Correct Answer: An XML backbone with PDF documents enabling lifecycle management of submissions
Q8. Why is climatic zone classification important when planning stability studies for ASEAN submissions?
- It determines the long-term and accelerated storage conditions reflecting hot and humid climates
- It defines the manufacturing temperature limits for GMP sites
- It specifies the solvent systems to be used in analytical methods
- It dictates the clinical trial eligibility criteria
Correct Answer: It determines the long-term and accelerated storage conditions reflecting hot and humid climates
Q9. What is the primary purpose of a bridging study in the context of using foreign clinical data for local ACTD submissions?
- To demonstrate that foreign clinical data are applicable to the local population and conditions
- To replace the requirement for any chemistry documentation
- To waive all pharmacovigilance obligations after approval
- To provide manufacturing batch release certificates only
Correct Answer: To demonstrate that foreign clinical data are applicable to the local population and conditions
Q10. For immediate-release oral generics submitted in ASEAN countries, which study is most commonly required to support interchangeability?
- Bioequivalence study
- Full new drug clinical efficacy trial
- Long-term carcinogenicity study in two species
- Complete pharmacokinetic modeling without in vivo data
Correct Answer: Bioequivalence study
Q11. Who is the primary authority responsible for technical review and approval of an ACTD submission within each Asian country?
- The national regulatory authority (country’s drug regulatory agency)
- The ASEAN Secretariat in Jakarta
- An appointed international contract research organization only
- A regional commercial distributor
Correct Answer: The national regulatory authority (country’s drug regulatory agency)
Q12. Which type of content is included in ACTD Module 2?
- Overviews and critical summaries of the quality, nonclinical and clinical information contained in Modules 3–5
- Detailed batch manufacturing records and raw data tables
- Country-specific application forms and labels
- Local GMP inspection reports only
Correct Answer: Overviews and critical summaries of the quality, nonclinical and clinical information contained in Modules 3–5
Q13. Which of the following is NOT part of Module 3 (Quality) of the ACTD?
- Clinical study reports
- Drug substance and drug product characterisation
- Specifications and analytical methods
- Manufacturing process descriptions
Correct Answer: Clinical study reports
Q14. Which dossier elements commonly require translation into the local language for many Asian regulatory submissions?
- Module 1 items such as the label, patient leaflet and signed application forms
- Raw chromatograms from all stability runs
- Standard operating procedures from foreign QC labs
- All Module 3 analytical method validation reports entirely in local language
Correct Answer: Module 1 items such as the label, patient leaflet and signed application forms
Q15. Which country-specific regulatory element related to post-marketing safety is typically provided in Module 1 of an ACTD submission?
- National pharmacovigilance system details and safety reporting commitments
- Complete immunogenicity raw data for biologics only
- International pricing and reimbursement approvals
- Global marketing strategies
Correct Answer: National pharmacovigilance system details and safety reporting commitments
Q16. Which statement correctly contrasts ACTD and eCTD submissions?
- eCTD is an electronic lifecycle submission standard (XML backbone) while ACTD refers to the dossier content framework often submitted in paper or electronic form
- ACTD is always electronic and eCTD is always paper
- They are identical standards with no practical differences
- eCTD is used only for clinical trials and ACTD only for manufacturing licenses
Correct Answer: eCTD is an electronic lifecycle submission standard (XML backbone) while ACTD refers to the dossier content framework often submitted in paper or electronic form
Q17. What is one of the most common causes for an ACTD submission being administratively rejected at initial filing in many Asian agencies?
- Incomplete or missing Module 1 documents such as local application forms, certificates or translations
- Too much stability data provided in Module 3
- Inclusion of clinical data in Module 3 instead of Module 5
- Using an eCTD format instead of paper
Correct Answer: Incomplete or missing Module 1 documents such as local application forms, certificates or translations
Q18. The ACTD concept and structure were largely influenced by which international guideline?
- ICH Common Technical Document (CTD)
- WHO Good Distribution Practice
- EMA Pediatric Regulation
- US FDAs Orange Book
Correct Answer: ICH Common Technical Document (CTD)
Q19. What is the primary purpose of the Quality Overall Summary (QOS) in Module 2 of an ACTD?
- To provide a concise, scientifically critical summary of the quality (CMC) information presented in Module 3
- To list the national regulatory fees and payment receipts
- To replace the need for Module 3 entirely
- To summarize only clinical safety data
Correct Answer: To provide a concise, scientifically critical summary of the quality (CMC) information presented in Module 3
Q20. For biological products submitted in ACTD format, which module requires detailed characterization, potency assays and batch consistency information?
- Module 3 (Quality)
- Module 4 (Nonclinical)
- Module 1 (Administrative)
- Module 5 (Clinical)
Correct Answer: Module 3 (Quality)

I am a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. I hold a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research. With a strong academic foundation and practical knowledge, I am committed to providing accurate, easy-to-understand content to support pharmacy students and professionals. My aim is to make complex pharmaceutical concepts accessible and useful for real-world application.
Mail- Sachin@pharmacyfreak.com

